Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurel Perren

Showing results (171-180 of 236) with videos related to

Pageof 24
Sort By:
Journal of Neuroendocrinology|October 28, 2022
High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intentElettra Merola, Aurel Perren, Anja Rinke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 17, 2026
MetAssist 2.0: A Generalizable AI Framework for Lymph Node Metastasis Detection Across Multiple Cancer TypesJavier Garcia-Baroja, Bastian Dislich, Philipp Zens, et al.
Journal of Neuroendocrinology|August 14, 2023
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromesJohannes Hofland, Massimo Falconi, Emanuel Christ, et al.
Onkologie|March 2, 2011
Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs)Gilbert Spizzo, Karin Bernardini, Oreste Pieramico, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2024
ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and OutcomeElisa Moser, Ayako Ura, Loreen Vogel, et al.
Purinergic Signalling|April 13, 2011
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancerBeat M Künzli, Maria-Isabell Bernlochner, Stephan Rath, et al.
JCO Precision Oncology|February 8, 2023
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine CarcinomaStian Knappskog, Tobias Grob, Andreas Venizelos, et al.
Neuroendocrinology|May 11, 2010
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumorsMarianne Pavel, Ashley Grossman, Rudolf Arnold, et al.
The American Journal of Surgical Pathology|December 7, 2007
WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumorsAnja M Schmitt, Martin Anlauf, Valentin Rousson, et al.
Neuroendocrinology|April 10, 2017
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical MarkersKjell Oberg, Anne Couvelard, Gianfranco Delle Fave, et al.
Pageof 24

Showing results (171-180 of 236) with videos related to

Sort By:
Pageof 24
Journal of Neuroendocrinology|October 28, 2022
High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intentElettra Merola, Aurel Perren, Anja Rinke, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 17, 2026
MetAssist 2.0: A Generalizable AI Framework for Lymph Node Metastasis Detection Across Multiple Cancer TypesJavier Garcia-Baroja, Bastian Dislich, Philipp Zens, et al.
Journal of Neuroendocrinology|August 14, 2023
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromesJohannes Hofland, Massimo Falconi, Emanuel Christ, et al.
Onkologie|March 2, 2011
Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs)Gilbert Spizzo, Karin Bernardini, Oreste Pieramico, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2024
ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and OutcomeElisa Moser, Ayako Ura, Loreen Vogel, et al.
Purinergic Signalling|April 13, 2011
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancerBeat M Künzli, Maria-Isabell Bernlochner, Stephan Rath, et al.
JCO Precision Oncology|February 8, 2023
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine CarcinomaStian Knappskog, Tobias Grob, Andreas Venizelos, et al.
Neuroendocrinology|May 11, 2010
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumorsMarianne Pavel, Ashley Grossman, Rudolf Arnold, et al.
The American Journal of Surgical Pathology|December 7, 2007
WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumorsAnja M Schmitt, Martin Anlauf, Valentin Rousson, et al.
Neuroendocrinology|April 10, 2017
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical MarkersKjell Oberg, Anne Couvelard, Gianfranco Delle Fave, et al.
Pageof 24